Literature DB >> 9671405

Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.

S Vallian1, J A Gäken, E B Gingold, T Kouzarides, K S Chang, F Farzaneh.   

Abstract

The growth and transformation suppressor function of promyelocytic leukemia (PML) protein are disrupted in acute promyelocytic leukemia (APL) as a result of its fusion to the RARalpha gene by t(15;17) translocation. There is significant sequence homology between the dimerization domain of PML and the Fos family of proteins, which imply that PML may be involved in AP-1 activity. Here we show that PML can cooperate with Fos to stimulate its AP-1-mediated transcriptional activity. Cotransfection of PML with GAL4/Fos strongly induced Fos-mediated activation of GAL4-responsive reporters, indicating a functional interaction between Fos and PML in vivo. Deletion analysis of Fos and PML demonstrated that the intact C-terminal domain of Fos (containing the dimerization domain), and the RING-finger, B1 box and nuclear localization domains of PML are involved in the cooperative activity of Fos and PML. Immunoprecipitation and electrophoretic mobility shift assay showed that PML is associated with the AP-1 complex. PMLRARalpha was also found to enhance the transcriptional activity of GAL4/Fos. The addition of retinoic acid abrogated the PMLRARalpha, but not PML-induced stimulation of GAL4/Fos activity in a dose-dependent manner. This study demonstrated that PML is involved in the AP-1 complex and can modulate Fos-mediated transcriptional activity, which may contribute to its growth suppressor function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671405     DOI: 10.1038/sj.onc.1201837

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.

Authors:  Gregory J Block; Christopher H Eskiw; Graham Dellaire; David P Bazett-Jones
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

2.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

3.  MOZ increases p53 acetylation and premature senescence through its complex formation with PML.

Authors:  Susumu Rokudai; Oleg Laptenko; Suzzette M Arnal; Yoichi Taya; Issay Kitabayashi; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

4.  The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.

Authors:  Julia Berscheminski; Peter Groitl; Thomas Dobner; Peter Wimmer; Sabrina Schreiner
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

5.  The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases.

Authors:  W S Wu; S Vallian; E Seto; W M Yang; D Edmondson; S Roth; K S Chang
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

6.  The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.

Authors:  Youn-Hee Choi; Rosa Bernardi; Pier Paolo Pandolfi; Etty N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

7.  Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

Authors:  Y Xu; J H Ahn; M Cheng; C M apRhys; C J Chiou; J Zong; M J Matunis; G S Hayward
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  PML colocalizes with and stabilizes the DNA damage response protein TopBP1.

Authors:  Zhi-Xiang Xu; Anna Timanova-Atanasova; Rui-Xun Zhao; Kun-Sang Chang
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

9.  Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.

Authors:  Pascal Lopez; Robert J Jacob; Bernard Roizman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.

Authors:  S Vallian; K V Chin; K S Chang
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.